Myomo and GRE to Conduct Screening Days in Ohio and Detroit

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, and Geauga Rehabilitation Engineering (GRE) have announced a series of free screening days to be held at the offices of GRE and its local partners near Cleveland, Detroit, Columbus and Cincinnati.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180214005214/en/

MyoPro is a powered upper limb orthosis designed to support the arm and restore function to weakened or paralyzed arms. (Photo: Business Wire)

At these events, certified MyoPro specialists will, at no charge, evaluate patients suffering a weakened or paralyzed arm from stroke, brachial plexus injury or other neuromuscular disease or injury to determine whether the MyoPro powered orthosis might be able to help restore function to that arm.

Myomo manufactures MyoPro and GRE is one of the Company’s regional Centers of Excellence (COE) located across the country that fit and deliver the device to patients.

“MyoPro braces are meeting an unmet need, and many patients are excited to learn how this life-changing product can help them,” said Myomo Chairman and CEO Paul R. Gudonis. “Staging these open screening days allows patients to try on a MyoPro so they can see for themselves how it might change their lives.”

Vince Baroni, Clinical Director of GRE, said “We piloted these screening days last month to great reception from patients. Several have already decided, with their doctors, that MyoPro is right for them. We’re excited to continue leveraging this awareness channel.”

Patients interested in trying a MyoPro at one of these screening days may register online for a session near them:

Feb. 21, Columbus: www.greop.com/free-evaluation-screening-columbus-2018
Feb. 22, Cleveland: www.greop.com/free-evaluation-screening-cleveland-2018
Feb. 23, Detroit: www.greop.com/free-evaluation-screening-detroit-2018
Feb. 28, Cincinnati: www.greop.com/free-evaluation-screening-cincinnati-2018

Myomo is working with other MyoPro COEs across the country to organize similar screening days in their service areas.

About Myomo

Myomo, Inc. is a commercial stage medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.

Forward Looking Statements

This press release contains forward-looking statements regarding the Company's future business expectations, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are only predictions and may differ materially from actual results due to a variety of factors. Our actual results could differ materially from those anticipated in these forward looking statements for many reasons, including, without limitation, risks related to regulatory approval and market acceptance of our products, and the other risk factors contained in our filings made with the Securities and Exchange Commission. More information about factors that potentially could affect Myomo's financial results is included in Myomo's filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The Company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180214005214/en/